Biomea Fusion doses first patient in obesity combo drug study
Go back to Biomea Fusion doses first patient in obesity combo drug study| (NASDAQ: BMEA) | Delayed: 1.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.71 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $ | |||
| Volume | 4,861 | |||||
